GeneDx Holdings Corp Ordinary Shares - Class A WGS 深 沪
等待开盘 12-19 09:30:00 美东时间
136.32
+0.380
+0.28%
华盛通- 最 高140.44
- 今 开138.99
- 成交量 37.33万股
- 最 低 132.18
- 昨 收 135.94
- 总市值 39.40亿
- 52周最高 170.87
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 55.17
- 委 比 -54.44%
- 总股本 2890.46万
- 历史最高 896.94
- 量 比 0.80
- 振 幅 6.08%
- 历史最低 2.466
- 每 手 1
- 风险率 27.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多7.1万亿！高盛警告：今日市场恐迎“火山爆发”，史上最大期权到期潮来袭
高盛发出预警：本周五将迎来史上最大规模的期权到期潮，名义风险敞口高达7.1万亿美元。“四巫日”魔咒再临，交易员已严阵以待！
今天 09:34
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
12-16 09:36
GeneDx's GUARDIAN Study Honored By JAMA For Demonstrating Genomic Newborn Screening Can Detect Serious Childhood Conditions Missed By Traditional Methods
Prestigious recognition underscores the impact of large-scale genomic screening in identifying serious childhood genetic conditions in conjunction with traditional newborn screeningGeneDx (NASDAQ:WGS), a leader in
12-15 21:55
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
12-15 15:30
BTIG Maintains Buy on GeneDx Holdings, Raises Price Target to $200
BTIG analyst Mark Massaro maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and raises the price target from $165 to $200.
12-12 19:09
6 Healthcare Stocks With Strong Upward Momentum
Out with the old (tech), in with the new (healthcare). After several volatile w...
11-19 01:59
GeneDx To Present Four Research Sessions At The 2025 National Society Of Genetic Counselors Annual Meeting, Showcasing Advances Powered By Its Genedx Infinity Platform
Powered by GeneDx Infinity™ with unparalleled scale and diversity, GeneDx fuels breakthrough scientific research and delivers the most precise rare disease diagnosis for patients and familiesGeneDx (NASDAQ:WGS), a
11-06 21:13
美股大行评级 | 最高255美元！9家大行集体上调Palantir目标价；Axsome、Exact、Fabrinet、ZoomInfo、爱德士、MongoDB、安森美半导体等也获多家大行上调目标价
今日重点评级关注：瑞银：维持Syndax Pharmaceuticals"买入"评级，目标价从35美元升至38美元；HC Wainwright & Co.：维持Benitec Biopharma"买入"评级，目标价从28美元升至35美元
11-05 10:35
美股大行评级 | 275美元！美银证券上调英伟达目标价；花旗上调思佳讯评级至"中性"，目标价从66美元升至91美元
今日重点评级关注：HC Wainwright & Co.：维持Unicycive Therapeutics"买入"评级，目标价从9美元升至22美元；花旗：维持Arcus Biosciences"买入"评级，目标价从54美元升至56美元
10-30 14:22
BTIG Maintains Buy on GeneDx Holdings, Raises Price Target to $165
BTIG analyst Mark Massaro maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and raises the price target from $140 to $165.
10-29 17:47
